254 related articles for article (PubMed ID: 6874888)
21. Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs.
Ohneda A; Kobayashi T; Nihei J
Diabetologia; 1986 Jun; 29(6):397-401. PubMed ID: 3527839
[TBL] [Abstract][Full Text] [Related]
22. Differences in molecular heterogeneity of glucagon-like immunoreactivity in plasma and liver metastases of a patient with alpha-cell tumor.
Kohnert KD; Kändler C; Woltanski KP; Ziegler M
Exp Clin Endocrinol; 1985 Feb; 85(1):89-94. PubMed ID: 2985414
[TBL] [Abstract][Full Text] [Related]
23. Glicentin and gastric inhibitory polypeptide immunoreactivity in endocrine cells of the gut and pancreas.
Larsson LI; Moody AJ
J Histochem Cytochem; 1980 Sep; 28(9):925-33. PubMed ID: 6997368
[TBL] [Abstract][Full Text] [Related]
24. Necrolytic migratory erythema with elevated plasma enteroglucagon in celiac disease.
Kelly CP; Johnston CF; Nolan N; Keeling PW; Weir DG
Gastroenterology; 1989 May; 96(5 Pt 1):1350-3. PubMed ID: 2703119
[TBL] [Abstract][Full Text] [Related]
25. Glucagon-related peptides in the human gastrointestinal mucosa.
Baldissera FG; Holst JJ
Diabetologia; 1984 Mar; 26(3):223-8. PubMed ID: 6546922
[TBL] [Abstract][Full Text] [Related]
26. [Studies on the relation between late dumping syndrome and glucagon responses to glucose].
Matsui T
Nihon Heikatsukin Gakkai Zasshi; 1988 Jun; 24(3):159-70. PubMed ID: 3073247
[TBL] [Abstract][Full Text] [Related]
27. Response of plasma and tissue levels of enteroglucagon immunoreactivity to intestinal resection, lactation and hyperphagia.
Jacobs LR; Bloom SR; Dowling RH
Life Sci; 1981 Nov; 29(19):2003-7. PubMed ID: 6947134
[No Abstract] [Full Text] [Related]
28. A large molecular form of glucagon-like peptide-1 (GLP-1) immunoreactivity is co-released with glucagon from pancreas by arginine in normal subjects.
Hirota M; Shimizu I; Ohboshi C; Nishino T; Shima K
Clin Chim Acta; 1987 Aug; 167(3):293-302. PubMed ID: 3304721
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation.
Meryn S; Stein D; Straus EW
Int J Obes; 1986; 10(1):37-42. PubMed ID: 3710688
[TBL] [Abstract][Full Text] [Related]
30. Oxyntomodulin (glicentin-(33-69)): pharmacokinetics, binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs.
Baldissera FG; Holst JJ; Knuhtsen S; Hilsted L; Nielsen OV
Regul Pept; 1988 May; 21(1-2):151-66. PubMed ID: 2839871
[TBL] [Abstract][Full Text] [Related]
31. Effects of acute and chronic ethanol administration on the gastrointestinal hormones gastrin, enteroglucagon, pancreatic glucagon and peptide YY in the rat.
Simanowski UA; Hubalek K; Ghatei MA; Bloom SR; Polak JM; Seitz HK
Digestion; 1989; 42(3):167-73. PubMed ID: 2767348
[TBL] [Abstract][Full Text] [Related]
32. An enteroglucagon tumour.
Bloom SR
Gut; 1972 Jul; 13(7):520-3. PubMed ID: 5069726
[TBL] [Abstract][Full Text] [Related]
33. Plasma enteroglucagon related to malabsorption in coeliac disease.
Kilander AF; Dotevall G; Lindstedt G; Lundberg PA
Gut; 1984 Jun; 25(6):629-35. PubMed ID: 6735247
[TBL] [Abstract][Full Text] [Related]
34. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
Blache P; Kervran A; Martinez J; Bataille D
Anal Biochem; 1988 Aug; 173(1):151-9. PubMed ID: 3189794
[TBL] [Abstract][Full Text] [Related]
35. The hormonal pattern of intestinal adaptation. A major role for enteroglucagon.
Bloom SR; Polak JM
Scand J Gastroenterol Suppl; 1982; 74():93-103. PubMed ID: 6959245
[TBL] [Abstract][Full Text] [Related]
36. Changes in glucagon kinetics and processing in patients with acute pancreatitis.
Tanjoh K; Tomita R; Ishikawa Y; Izumi T; Kinoshita K; Azuhata T
Hepatogastroenterology; 2007 Jun; 54(76):1250-5. PubMed ID: 17629081
[TBL] [Abstract][Full Text] [Related]
37. The biological significance of "enteroglucagon." Present status.
Bataille D; Jarrousse C; Kervran A; Depigny C; Dubrasquet M
Peptides; 1986; 7 Suppl 1():37-42. PubMed ID: 3529053
[TBL] [Abstract][Full Text] [Related]
38. Immunofluorescent localization of enteroglucagon cells in the gastrointestinal tract of the dog.
Polak JM; Bloom S; Coulling I; Pearse AG
Gut; 1971 Apr; 12(4):311-8. PubMed ID: 4930155
[TBL] [Abstract][Full Text] [Related]
39. Determination of enteroglucagon in plasma for detection of celiac disease in children.
Kilander AF; Stenhammar L; Lindstedt G; Lundberg PA
Clin Chem; 1984 Jan; 30(1):77-80. PubMed ID: 6690155
[TBL] [Abstract][Full Text] [Related]
40. Measurement and partial characterization of immunoreactive glucagon in gastrointestinal tissues of dogs.
Morita S; Doi K; Yip CC; Vranic M
Diabetes; 1976 Nov; 25(11):1018-25. PubMed ID: 186345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
